Experts are evaluating a new cancer treatment that has shown potential. This treatment involves a vaccine developed by Moderna in collaboration with another company. The vaccine was tested alongside an existing immunotherapy treatment for melanoma.

Regulatory approval is needed before the vaccine can be used to help patients. If approved, it could benefit a large number of people who have had high-risk tumors removed.

Further information about this development is available, including comments from a representative of Moderna.